CDK2 and neoplasm: Because of that, the tumor immune infiltration of T cell is closely associated with the efficiency of the immune checkpoint inhibitor therapy [64]; thus, we evaluated the impact of the expression of STAT3/CDK2/4/6 on the therapeutic outcome of immune checkpoint blockade.